Descemet membrane endothelial keratoplasty (DMEK) is becoming an increasingly popular method of corneal transplantation. Dr Alain Saad explains that this is likely due to the quicker recovery time, better visual acuity, and lower complication rate associated with DMEK. He also describes some of the challenges that can be experienced during surgery, and how many of these can be overcome with comprehensive training and good instrumentation. Finally, Dr Saad looks ahead to the future of DMEK.
1. We tend to see a real hype on Descemet membrane endothelial keratoplasty (DMEK), compared to other corneal transplantation techniques, such as penetrating keratoplasty. What is your personal rationale for the rising popularity of this surgical technique? (0:08)
2. Why is it so challenging and where do you see the most critical steps in preparation and in transplantation? (1:07)
3. What is your recommendation and what are your pearls on how to master those challenges? (2:46)
4. Where do you see DMEK going to – what will the future bring? (3:43)
Speaker disclosures: Alain Saad is a consultant for Geuder and Bausch+Lomb.
Support: This video interview was supported by Geuder.
Filmed at the 36th Congress of the European Society of Cataract & Refractive Surgeons (ESCRS), Vienna, Austria, 22–26 September 2018
Share this Video
Related Videos In Corneal Disorders
Jorge L Alió, EGS 2020 – Corneal Regeneration, Will It Be a Reality in 2021?
We were delighted to talk with our Editorial Board member, Jorge L. Alió (Miguel Hernández University of Alicante, Elche, Spain) about the recent technological advances in corneal regeneration. Questions Could you tell us a little about the challenges and opportunities of corneal regeneration? (0:05) What have been the most exciting recent technological advances in corneal […]
Farhad Hafezi, ESCRS 2020 – PACK-CXL Multicentre Trial (Part 2)
It was a pleasure to catch up with our Editorial Board member Prof. Farhad Hafezi (ELZA Institute, Zurich, Switzerland), the winner of the ESCRS 2020 Refractive Award! Here he discusses the PACK-CXL multicentre trial, and the benefits of this treatment. Questions Which patients are likely to benefit most from photoactivated chromophore for keratitis-corneal collagen cross-linking […]
Farhad Hafezi, ESCRS 2020 – PACK-CXL Multicentre Trial (Part 1)
It was a pleasure to catch up with our Editorial Board member Prof. Farhad Hafezi (ELZA Institute, Zurich, Switzerland), the winner of the ESCRS 2020 Refractive Award! Here he discusses the PACK-CXL multicentre trial, and the benefits of this treatment. Questions What are the major challenges in the treatment of infectious keratitis? (00:15) Could you […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!